Capital Partners Invests in Allentown, Inc.

Lead Capital Partners and Petra Capital Partners Invest in Lieberman

January 30, 2025

Marketing & Advertising

Lead Capital Partners and Petra Capital Partners made a strategic platform investment in Lieberman, Inc., a custom primary market research and analytics firm. The investment will support Lieberman's growth and capability expansion while the company remains led by its existing management team.

Aterian Investment Partners Acquires Majority Interest in Allentown, LLC

May 9, 2022

Medical Devices

Aterian Investment Partners has acquired a majority interest in Allentown, LLC, a 50+-year provider of vivarium laboratory equipment and solutions based in Allentown, New Jersey. The transaction — Aterian’s first investment from its Fund IV — was completed from Heartwood Partners (Heartwood Partners Fund III, LP), with Aterian positioning Allentown as a platform for further organic growth and M&A in the life‑sciences equipment/manufacturing space.

L Catterton Makes Growth Investment in Alliance Animal Health

January 20, 2022

Healthcare Services

Alliance Animal Health, a U.S. multi-site owner and operator of veterinary hospitals, received a significant growth investment from the Flagship Fund of L Catterton. LightBay Capital will retain a significant minority stake; terms were not disclosed. The capital is intended to support continued investments in hospitals, training, recruitment and geographic expansion.

Ampersand Capital Partners Invests in Alliance Pharma

November 18, 2021

Healthcare Services

Ampersand Capital Partners has made a growth equity investment in Alliance Pharma, a Malvern, Pennsylvania–based bioanalytical CRO. The funding will support Alliance’s expansion of global reach, scientific capabilities, and operational capacity while founder Frank Li remains a significant shareholder.

Ampersand Capital Partners Majority Recapitalizes Leinco Technologies

November 10, 2021

Biotechnology

Ampersand Capital Partners has completed a majority recapitalization of Leinco Technologies, a specialty manufacturer of life-science reagents and custom development services based near St. Louis, Missouri. The growth equity investment will fund expanded manufacturing capacity, broaden scientific capabilities and product offerings, and support Leinco's commercial and geographic expansion while leadership including founder Pat Leinert Sr. remain involved.

Ampersand Capital Partners Recapitalizes American Laboratory Products Company (ALPCO)

September 21, 2020

Medical Devices

Ampersand Capital Partners completed a majority recapitalization of American Laboratory Products Company (ALPCO) to provide growth capital for expanding ALPCO's diagnostics test kit offering, geographic reach, and R&D/production capabilities. Founders Richard and Jan Conley will remain shareholders, Sean Conley will continue as CEO, and Larry McCarthy, PhD was named Board Chairman.